News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Novartis
NEWS
JOBS
IN THE PRESS
NEWS
Business
Novartis AG Scoops Up U.S. Sickle Cell Drugmaker Selexys in $665 Million Deal
November 21, 2016
·
2 min read
Deals
Novartis AG Is Gearing Up For A Huge Makeover
November 17, 2016
·
1 min read
Deals
Novartis AG Reportedly in Talks to Buy New Jersey’s Amneal, Deal Could be Worth $8 Billion
November 14, 2016
·
2 min read
Drug Development
Sanofi and Novartis AG are the Worst Culprits in Reporting Clinical Trial Data, Shire the Best
November 4, 2016
·
2 min read
Genetown
Novartis AG Is Challenging Biogen On Biogen’s Own Turf
October 27, 2016
·
1 min read
Biotech Bay
Novartis AG CEO Thinks The Drug Pricing Debate Will Get “More Difficult” In The Next 3-5 Years
October 26, 2016
·
1 min read
Job Trends
This is Why Novartis AG Folded Its CAR-T Unit
October 26, 2016
·
3 min read
Deals
Novartis AG Has Up to $5 Billion Burning in Its Pocket for M&As
October 26, 2016
·
1 min read
Deals
Merck & Co. and Novartis AG CEOs Blueprint What’s on Their M&A Wish List for 2017
October 26, 2016
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Novartis Canada Reopens NOYCIA 2026, Continuing Its Longstanding Investment in the Future of Oncology Research
March 30, 2026
·
2 min read
Press Releases
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
March 30, 2026
·
10 min read
Press Releases
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
March 27, 2026
·
6 min read
Press Releases
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026
March 23, 2026
·
5 min read
Press Releases
Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program
March 20, 2026
·
2 min read
Press Releases
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
March 20, 2026
·
6 min read
Press Releases
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
March 15, 2026
·
11 min read
Press Releases
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
March 6, 2026
·
4 min read
Press Releases
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
March 1, 2026
·
8 min read
Press Releases
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
March 1, 2026
·
4 min read
